4.7 Article

Estrogen Receptor (ER) β Regulates ERα Expression in Stromal Cells Derived from Ovarian Endometriosis

期刊

出版社

OXFORD UNIV PRESS INC
DOI: 10.1210/jc.2008-1466

关键词

-

资金

  1. National Institutes of Health [HD38691, HD40093]
  2. Friends of Prentice

向作者/读者索取更多资源

Context: Estradiol and its nuclear receptors, estrogen receptor (ER) alpha and ER beta, play critical roles in endometrium and endometriosis. Levels of ER beta, due to pathological hypomethylation of its promoter, are significantly higher in endometriotic vs. endometrial tissue and stromal cells, whereas ER alpha levels are lower in endometriosis. Estradiol regulates ER alpha gene expression via its alternatively used promoters A, B, and C. Objective: The aim of the study was to determine whether high levels of ER beta in endometriotic stromal cells from ovarian endometriomas regulate ER alpha gene expression. Results: ER beta knockdown significantly increased ER alpha mRNA and protein levels in endometriotic stromal cells. Conversely, ER beta overexpression in endometrial stromal cells decreased ER alpha mRNA and protein levels. ER beta knockdown significantly decreased proliferation of endometriotic stromal cells. Chromatin immunoprecipitation assays demonstrated that estradiol enhanced ER beta binding to nonclassical activator protein 1 and specificity protein 1 motifs in the ER alpha gene promoters A and C and a classic estrogen response element in promoter B in endometriotic stromal cells. Conclusions: High levels of ER beta suppress ER alpha expression and response to estradiol in endometrial and endometriotic stromal cells via binding to classic and nonclassic DNA motifs in alternatively used ER alpha promoters. ER beta also regulates cell cycle progression and might contribute to proliferation of endometriotic stromal cells. We speculate that a significantly increased ratio of ER beta: ER alpha in endometriotic tissues may also suppress progesterone receptor expression and contribute to progesterone resistance. Thus, ER beta may serve as a significant therapeutic target for endometriosis. (J Clin Endocrinol Metab 94: 615-622, 2009)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据